Skip to content

Mesa Laboratories MLAB Deferred Taxes

Deferred Taxes at other companies

NeoGenomics logo
NeoGenomicsNEO
$17.45M-16.8%
ICU Medical logo
ICU MedicalICUI
$14.51M-68.1%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
Charles River Laboratories logo
Charles River LaboratoriesCRL
TEC
Bio-TechneTECH

Other financials

Income statement

See full
Revenue$63.7M+2.6%
Gross profit$31.2M-0.5%
Operating income-$664.0K+85.5%
Net income$3.6M+317%
EPS (diluted)-$0.10+63.0%

Balance sheet

See full
Cash & equivalents$26.9M-1.4%
Total debt$78.7M-53.1%
Total equity$186.2M+16.5%
Total assets$427.7M-1.3%

Cash flow

See full
Operating cash flow$14.0M+10.2%
CapEx$417.0K-44.9%
Free cash flow$13.5M+13.7%

Valuation

See full
Market cap$542.27M+3.7%
Enterprise value$594.05M-10.4%
P/S2.2×0.0×

Profitability

See full
Gross margin56.8%
Operating margin2.3%
Net margin1.5%+0.8pp
FCF margin15.9%-1.8pp

Returns & leverage

See full
Return on equity2.2%+1.1pp
Debt / equity0.4×-0.6×
Current ratio1.7×+1.1×

Where this comes from

Reported directly by Mesa Laboratories in its filing.

Tagged under the XBRL concept us-gaap:DeferredIncomeTaxLiabilitiesNet.

The official record: Mesa Laboratories’s 10-K, filed June 3, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mesa Laboratories's deferred taxes.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Mesa Laboratories's deferred taxes?
Mesa Laboratories (MLAB) reported deferred taxes of $20.09M in Q1 2026.
How has Mesa Laboratories's deferred taxes changed year-over-year?
Mesa Laboratories's deferred taxes decreased by 0.5% year-over-year, from $20.18M to $20.09M.
What is the long-term trend for Mesa Laboratories's deferred taxes?
Over 3 years (2021 to 2026), Mesa Laboratories's deferred taxes has grown at a 7.3% compound annual growth rate (CAGR), from $16.28M to $20.09M.
What does deferred taxes mean?
This represents the net amount of income taxes that will be payable in future periods due to temporary differences between the carrying amount of assets and liabilities for financial reporting and their tax bases. It reflects the long-term tax impact of accounting choices and depreciation schedules. Investors use this to understand future tax obligations and the impact of tax timing on cash flow.